Outcomes of Restrictive Cardiomyopathy in Japanese Children - A Retrospective Cohort Study

Circ J. 2022 Nov 25;86(12):1943-1949. doi: 10.1253/circj.CJ-21-0706. Epub 2021 Dec 21.

Abstract

Background: There has been no nationwide survey on the prognosis of pediatric restrictive cardiomyopathy (RCM) in Japan; therefore, this retrospective multicentered study was designed to investigate the long-term survival rate of pediatric patients with RCM in Japan.Methods and Results: A multicentered, retrospective observational study was performed between 1990 and 2014 and included patients diagnosed with RCM who were aged <18 years from 18 Japanese institutions. A total of 54 patients were diagnosed with RCM. The median age at diagnosis was 4.4 years, and the median duration of observation was 2.2 years at the time of this study. Of these patients, 54% had symptoms, including heart failure. Twelve patients died without heart transplantation, mostly due to heart failure. The median time to death from diagnosis was 2.5 years. Freedom from death at 1, 5, and 10 years was 91%, 68%, and 62%, respectively. Death occurred within 5 years of diagnosis in most patients. Twenty-two patients underwent heart transplantation. Freedom from heart transplantation at 1, 5, and 10 years was 77%, 58%, and 53%, respectively. Freedom from death or heart transplantation at 1, 5, and 10 years was 72%, 40%, and 34%, respectively. The presence of symptoms was a risk factor for death or transplantation.

Conclusions: The prognosis of pediatric RCM is poor, and the heart transplantation rate is low in Japan.

Keywords: Children; Heart transplantation; Restrictive cardiomyopathy.

Publication types

  • Observational Study

MeSH terms

  • Cardiomyopathy, Restrictive* / etiology
  • Cardiomyopathy, Restrictive* / therapy
  • Child
  • Heart Failure* / complications
  • Heart Failure* / therapy
  • Heart Transplantation* / adverse effects
  • Humans
  • Japan / epidemiology
  • Retrospective Studies